Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 851.49B | 858.25B | 798.68B | 679.74B | 679.50B |
Gross Profit | 190.18B | 184.13B | 160.62B | 148.08B | 189.09B |
EBITDA | 82.05B | 76.91B | 59.55B | 58.35B | 54.91B |
Net Income | 34.69B | 31.74B | -10.38B | 17.51B | 19.01B |
Balance Sheet | |||||
Total Assets | 789.71B | 826.70B | 713.87B | 723.07B | 687.41B |
Cash, Cash Equivalents and Short-Term Investments | 96.12B | 109.47B | 82.97B | 70.71B | 61.73B |
Total Debt | 84.53B | 88.31B | 85.05B | 79.51B | 76.95B |
Total Liabilities | 287.14B | 310.32B | 275.38B | 262.43B | 242.64B |
Stockholders Equity | 485.01B | 500.30B | 423.88B | 449.27B | 433.20B |
Cash Flow | |||||
Free Cash Flow | 13.74B | 44.00B | 4.76B | 23.15B | 32.15B |
Operating Cash Flow | 55.21B | 73.19B | 23.42B | 41.83B | 49.51B |
Investing Cash Flow | -34.96B | -30.94B | 487.00M | -15.52B | -17.11B |
Financing Cash Flow | -35.43B | -19.54B | -10.63B | -17.85B | -31.26B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ¥491.08B | 14.35 | 3.13% | -1.27% | 6.01% | ||
67 Neutral | S$3.18B | 15.21 | 13.43% | 4.39% | 4.41% | -17.10% | |
― | $2.30B | 18.52 | 8.89% | 1.91% | ― | ― | |
― | $5.71B | 15.57 | 10.68% | 2.44% | ― | ― | |
― | $1.22B | 7.38 | 10.43% | 3.01% | ― | ― | |
― | $4.30B | 16.11 | 9.20% | 1.18% | ― | ― | |
― | €991.74M | 11.81 | 6.86% | 3.78% | ― | ― |
Nisshin Seifun Group Inc. reported its consolidated financial results for the first quarter of fiscal 2026, showing a slight increase in net sales by 0.7% compared to the previous year. However, there was a decline in operating profit and ordinary profit by 14.6% and 10.9% respectively, while profit attributable to owners of the parent increased by 7.1%. The company maintained a stable equity ratio and forecasts a modest growth in net sales and profits for the full fiscal year 2026.
The most recent analyst rating on (JP:2002) stock is a Hold with a Yen2000.00 price target. To see the full list of analyst forecasts on Nisshin Seifun Group Inc. stock, see the JP:2002 Stock Forecast page.
Nisshin Seifun Group Inc. has announced a plan to continue its strategy of issuing subscription rights to shares as a measure to enhance corporate value and protect shareholder interests. The company has filed a shelf registration for these rights, allowing for a prompt response if the plan is implemented, with a scheduled issuance amount of ¥642,198,000.
The most recent analyst rating on (JP:2002) stock is a Hold with a Yen2000.00 price target. To see the full list of analyst forecasts on Nisshin Seifun Group Inc. stock, see the JP:2002 Stock Forecast page.
Nisshin Seifun Group Inc. announced the continuation of its takeover response policies, initially introduced in 2006, to protect and enhance corporate value and shareholder interests. The plan involves the use of subscription rights to shares as a countermeasure against potential hostile takeovers, ensuring the company remains in control of its strategic direction and maintains stability for its stakeholders.
The most recent analyst rating on (JP:2002) stock is a Hold with a Yen2000.00 price target. To see the full list of analyst forecasts on Nisshin Seifun Group Inc. stock, see the JP:2002 Stock Forecast page.
Nisshin Seifun Group Inc. is restructuring its business portfolio to align with its Medium-Term Management Plan 2026, aiming for sustainable growth. As part of this restructuring, Nisshin Pharma will cease its fine chemicals business and transfer its healthcare foods business to Oriental Yeast Co., Ltd., which is expected to enhance the healthcare foods segment. This move is driven by a challenging business environment for Nisshin Pharma’s fine chemicals and aims to leverage Oriental Yeast’s capabilities in food materials. The restructuring will result in an extraordinary loss of 2,276 million yen, impacting the company’s financial results.
Nisshin Seifun Group Inc. reported a slight decrease in net sales and operating profit for the fiscal year ending March 31, 2025, compared to the previous year. Despite this, the company increased its dividends per share, indicating a commitment to shareholder returns. The forecast for the next fiscal year shows a modest growth in net sales and profits, suggesting a positive outlook for the company’s financial performance.